{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T02:39:52Z","timestamp":1722911992496},"reference-count":9,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T00:00:00Z","timestamp":1176854400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:p><jats:bold><jats:sc>Abstract<\/jats:sc>:\u2002<\/jats:bold>  <jats:bold>The presence of a chronic inflammatory state has also been widely documented in end\u2010stage renal disease patients receiving maintenance hemodialysis (HD). It is commonly attributed to the constantly renewed activation of circulating neutrophils and monocytes following blood passage through dialysis circuits and subsequent generation of activated complement components due to contact of plasma with bioincompatible membranes and\/or transfer of endotoxins from the dialyzate to the blood compartment. This conjunction leads to a massive generation of reactive oxygen species (ROS), for example, superoxide anion, hydrogen peroxide, hydroxyl radical, and chlorinated oxidants, such as hypochlorous acid by activated neutrophils. The exquisite vulnerability of proteins to ROS is now well documented. Oxidation of amino acid residues, such as tyrosine, leads to the formation of dityrosine, protein aggregation, cross\u2010linking, and fragmentation. Dityrosine\u2010containing protein cross\u2010linking products in the plasma of dialysis patients are named as advanced oxidation protein products (AOPP). In addition, advanced glycation end\u2010products (AGE) is a protein carbonyl compound and produced by protein\u2013ROS interaction. We investigated both the effect of the renewed activation of the immune cells, due to blood\u2013dialyzer interaction over protein oxidation products like AOPP and AGE, among chronic renal failure (CRF) patients receiving maintenance HD, and choice of dialyzers like high flux or the other group on protein oxidation product levels.<\/jats:bold> <\/jats:p>","DOI":"10.1196\/annals.1395.045","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T21:14:35Z","timestamp":1177535675000},"page":"404-408","source":"Crossref","is-referenced-by-count":22,"title":["Hemodialysis and Protein Oxidation Products"],"prefix":"10.1111","volume":"1100","author":[{"given":"C\u0130HAN","family":"CO\u015eKUN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALEV","family":"KURAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASEM\u0130N","family":"D\u00d6VENTA\u015e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAC\u0130T","family":"KOLDA\u015e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00dcMEYRA","family":"\u00d6ZTURK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BERR\u0130N BER\u00c7\u0130K","family":"\u0130NAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALPER","family":"G\u00dcM\u00dc\u015e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.07841.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200009000-00004"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_8.16"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.2.335"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00741.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.186"},{"key":"e_1_2_5_8_2","first-page":"336","article-title":"Oxidative stress and chronic renal failure: markers and management","volume":"15","author":"Massy Z.A.","year":"2002","journal-title":"J. Nephrol."},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.07833.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27695"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1395.045","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1395.045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:35:19Z","timestamp":1695605719000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1395.045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1196\/annals.1395.045"],"URL":"https:\/\/doi.org\/10.1196\/annals.1395.045","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}